Advantest Co. (OTCMKTS:ATEYY – Get Free Report) saw a significant growth in short interest during the month of March. As of March 15th, there was short interest totalling 15,300 shares, a growth of 128.4% from the February 28th total of 6,700 shares. Based on an average daily volume of 410,900 shares, the short-interest ratio is currently 0.0 days. Currently, 0.0% of the shares of the stock are short sold.
Advantest Stock Down 4.5 %
Shares of OTCMKTS:ATEYY opened at $45.23 on Friday. The company has a market cap of $33.38 billion, a price-to-earnings ratio of 37.07 and a beta of 1.34. Advantest has a 12 month low of $31.52 and a 12 month high of $65.40. The company has a current ratio of 2.94, a quick ratio of 1.78 and a debt-to-equity ratio of 0.15. The company has a 50-day moving average price of $56.59 and a 200 day moving average price of $55.76.
Advantest (OTCMKTS:ATEYY – Get Free Report) last released its quarterly earnings results on Wednesday, January 29th. The company reported $0.46 EPS for the quarter. Advantest had a net margin of 19.95% and a return on equity of 29.15%. As a group, equities research analysts predict that Advantest will post 1.61 earnings per share for the current year.
Analyst Upgrades and Downgrades
Get Our Latest Stock Report on ATEYY
About Advantest
Advantest Corporation manufactures and sells semiconductors, component test system products, and mechatronics related products in Japan, the Americas, Europe, and Asia. The company operates through three segments: Semiconductor and Component Test System; Mechatronics Related Business; and Services, Support and Others.
Featured Articles
- Five stocks we like better than Advantest
- Why Are These Companies Considered Blue Chips?
- MarketBeat Week in Review – 03/24 – 03/28
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- How to Calculate Return on Investment (ROI)
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Advantest Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advantest and related companies with MarketBeat.com's FREE daily email newsletter.